The Cooper Companies Stock Forecast, Price & News

+4.87 (+1.17 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume178,294 shs
Average Volume272,750 shs
Market Capitalization$20.77 billion
P/E Ratio8.89
Dividend Yield0.01%
30 days | 90 days | 365 days | Advanced Chart
Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for The Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

The Cooper Companies logo

About The Cooper Companies

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.13 out of 5 stars

Medical Sector

159th out of 2,216 stocks

Ophthalmic Goods Industry

1st out of 8 stocks

Analyst Opinion: 1.3Community Rank: 3.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

The Cooper Companies (NYSE:COO) Frequently Asked Questions

Is The Cooper Companies a buy right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for The Cooper Companies in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" The Cooper Companies stock.
View analyst ratings for The Cooper Companies
or view top-rated stocks.

What stocks does MarketBeat like better than The Cooper Companies?

Wall Street analysts have given The Cooper Companies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Cooper Companies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is The Cooper Companies' next earnings date?

The Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, September 2nd 2021.
View our earnings forecast for The Cooper Companies

How were The Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NYSE:COO) posted its quarterly earnings results on Wednesday, June, 2nd. The medical device company reported $3.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.09 by $0.29. The medical device company had revenue of $719.50 million for the quarter, compared to analyst estimates of $691.63 million. The Cooper Companies had a trailing twelve-month return on equity of 12.02% and a net margin of 88.54%. The company's revenue was up 37.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.51 EPS.
View The Cooper Companies' earnings history

How has The Cooper Companies' stock been impacted by COVID-19?

The Cooper Companies' stock was trading at $323.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, COO shares have increased by 30.2% and is now trading at $421.77.
View which stocks have been most impacted by COVID-19

How often does The Cooper Companies pay dividends? What is the dividend yield for The Cooper Companies?

The Cooper Companies announced a Semi-Annual dividend on Wednesday, July 14th. Investors of record on Tuesday, July 27th will be given a dividend of $0.03 per share on Wednesday, August 11th. The ex-dividend date of this dividend is Monday, July 26th.
View The Cooper Companies' dividend history

Is The Cooper Companies a good dividend stock?

The Cooper Companies pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.01%. The Cooper Companies does not yet have a strong track record of dividend growth. The dividend payout ratio of The Cooper Companies is 0.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, The Cooper Companies will have a dividend payout ratio of 0.41% next year. This indicates that The Cooper Companies will be able to sustain or increase its dividend.
View The Cooper Companies' dividend history.

What guidance has The Cooper Companies issued on next quarter's earnings?

The Cooper Companies updated its FY 2021 earnings guidance on Tuesday, June, 29th. The company provided EPS guidance of $13.200-$13.400 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.040. The company issued revenue guidance of $2.86 billion-$2.89 billion, compared to the consensus revenue estimate of $2.83 billion.

What price target have analysts set for COO?

12 equities research analysts have issued 12 month target prices for The Cooper Companies' stock. Their forecasts range from $315.00 to $450.00. On average, they expect The Cooper Companies' stock price to reach $403.83 in the next year. This suggests that the stock has a possible downside of 4.3%.
View analysts' price targets for The Cooper Companies
or view top-rated stocks among Wall Street analysts.

Who are The Cooper Companies' key executives?

The Cooper Companies' management team includes the following people:
  • Mr. Albert G. White III, Pres, CEO & Non-Independent Director (Age 51, Pay $1.81M)
  • Mr. Brian G. Andrews, Exec. VP, CFO & Treasurer (Age 42, Pay $762.01k)
  • Mr. Daniel G. McBride, Exec. VP & COO (Age 57, Pay $1.14M)
  • Ms. Holly R. Sheffield, Pres of CooperSurgical, Inc. (Age 50, Pay $815.4k)
  • Mr. Agostino Ricupati, Sr. VP of Fin. & Tax and Chief Accounting Officer (Age 54)
  • Mr. Kim Duncan, VP of Investor Relations & Risk Management
  • Mr. Mark J. Drury, VP, Gen. Counsel & Corp. Sec. (Age 45)
  • Mr. Juan Carlos Aragón, Pres of CooperVision Specialty EyeCare Division

What is Robert S. Weiss' approval rating as The Cooper Companies' CEO?

8 employees have rated The Cooper Companies CEO Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among The Cooper Companies' employees.

Who are some of The Cooper Companies' key competitors?

What other stocks do shareholders of The Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Cooper Companies investors own include The Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

What is The Cooper Companies' stock symbol?

The Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Who are The Cooper Companies' major shareholders?

The Cooper Companies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.10%), State of Alaska Department of Revenue (0.07%), Oregon Public Employees Retirement Fund (0.02%), WD Rutherford LLC (0.02%), Bellecapital International Ltd. (0.02%) and IFM Investors Pty Ltd (0.02%). Company insiders that own The Cooper Companies stock include Agostino Ricupati, Albert G White III, Allan E Rubenstein, Gary S Petersmeyer, Holly R Sheffield, Jody S Lindell, Michael Kalkstein and Robert D Auerbach.
View institutional ownership trends for The Cooper Companies

Which institutional investors are selling The Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Kornitzer Capital Management Inc. KS, Bellecapital International Ltd., and Raymond James Trust N.A.. Company insiders that have sold The Cooper Companies company stock in the last year include Agostino Ricupati, Albert G White III, Gary S Petersmeyer, Jody S Lindell, and Robert D Auerbach.
View insider buying and selling activity for The Cooper Companies
or view top insider-selling stocks.

Which institutional investors are buying The Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Oregon Public Employees Retirement Fund, IFM Investors Pty Ltd, Wealth Advisory Solutions LLC, New Mexico Educational Retirement Board, and WD Rutherford LLC. Company insiders that have bought The Cooper Companies stock in the last two years include Agostino Ricupati, Albert G White III, and Holly R Sheffield.
View insider buying and selling activity for The Cooper Companies
or or view top insider-buying stocks.

How do I buy shares of The Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is The Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $421.77.

How much money does The Cooper Companies make?

The Cooper Companies has a market capitalization of $20.77 billion and generates $2.43 billion in revenue each year. The medical device company earns $238.40 million in net income (profit) each year or $9.64 on an earnings per share basis.

How many employees does The Cooper Companies have?

The Cooper Companies employs 12,000 workers across the globe.

Does The Cooper Companies have any subsidiaries?

The following companies are subsidiares of The Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.

When was The Cooper Companies founded?

The Cooper Companies was founded in 1958.

What is The Cooper Companies' official website?

The official website for The Cooper Companies is www.coopercos.com.

Where are The Cooper Companies' headquarters?

The Cooper Companies is headquartered at 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583.

How can I contact The Cooper Companies?

The Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.